Fact CheckerSign in

NCT04605822Completed

Melanoma Detection in Switzerland With VECTRA

Clinical Performance of the New Artificial-intelligence Powered 3D Total Body Photography System VECTRA® in Early Melanoma Detection and Its Impact on Patients' Burden of Disease: A Prospective Cohort Study in a Real-world Setting

Source: ClinicalTrials.gov · Last updated 19 Mar 2024

Brief summary (registry, in English)

This study is to compare 2D- and 3D-imaging and routine clinical care in early melanoma detection in a prospective large-scale real-world data set.

Status (registry)
Completed
Study type
Observational
Enrollment
455 (actual)
First submitted
21 Oct 2020
Start date
25 Jan 2021
Primary completion date
31 Jan 2024
Lead sponsor
University Hospital, Basel, Switzerland
Diseases
Melanoma
NCT number
NCT04605822

What you commit to

  • Study type: Observational
  • Participants enrolled: 455
  • From 25 Jan 2021 to the primary completion date, 31 Jan 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Acute psychiatric illness or acute crisis

Other

  • Lack of informed consent for study participation.
  • Fitzpatrick skin type V-VI.

Who the study is looking for

  • Written informed consent of the patient
  • Sufficient fluency in German language skills to complete all questionnaires of the study without external assistance
  • High-risk criteria for melanoma. For "high risk" one of the following criteria needs to be fulfilled:
    • At least one previous melanoma (including melanoma in situ)
    • A diagnosis of ≥ 100 nevi
    • A diagnosis of ≥ 5 atypical nevi
    • A diagnosis of dysplastic nevus syndrome or known CDKN2A mutation
    • A strong family history (≥ 1 first- and/or second-degree relatives)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Dermatology, University Hospital Basel
Coordinator of this site? Confirm its status
BaselSwitzerlandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.